SCGB2A2 and breast carcinoma: Two studies used adoptive CD8 cytotoxic T-cell transfer and engineered dendritic cells as proof of principle to induce immune responses against mammaglobin-A-positive breast cancer cells in mice [52] and cell cultures [53].